- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleic Acid Therapeutics for Neurological Diseases
Authors
Keywords
-
Journal
Neurotherapeutics
Volume 16, Issue 2, Pages 245-247
Publisher
Springer Science and Business Media LLC
Online
2019-04-30
DOI
10.1007/s13311-019-00736-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
- (2019) Anna M. Krichevsky et al. Neurotherapeutics
- Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
- (2019) Ronald A.M. Buijsen et al. Neurotherapeutics
- Nucleic Acid Therapies for Ischemic Stroke
- (2019) Nils Henninger et al. Neurotherapeutics
- Nucleic Acid–Based Therapeutics for Parkinson’s Disease
- (2019) Masayuki Nakamori et al. Neurotherapeutics
- Targeted Oligonucleotides for Treating Neurodegenerative Tandem Repeat Diseases
- (2019) Rula Zain et al. Neurotherapeutics
- Nucleic Acid-Based Therapeutics Relevant to Neuroimmune Conditions
- (2019) Ariele L. Greenfield et al. Neurotherapeutics
- Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction
- (2019) Michelle L. Hastings et al. Neurotherapeutics
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- A tailormade drug developed in record time may save girl from fatal brain disease
- (2018) Jocelyn Kaiser SCIENCE
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy
- (2017) David R Corey NATURE NEUROSCIENCE
- FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides
- (2017) Annemieke Aartsma-Rus Nucleic Acid Therapeutics
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now